• 제목/요약/키워드: Human follicular fluid

검색결과 60건 처리시간 0.028초

한우 난소의 Follicular Fluid의 특징과 과립막 세포의 스테로이드호르몬 분비에 대한 Anti-Inhibin Serum의 첨가효과 (Effects of Characteristics of Ovarian follicular Fluid and Ant-Inhibin Serum on Steroid Hormone Secretion by Hanwoo Granulosa Cells In Vitro)

  • 성환후;민관식;양병철;노환국;최선호;임기순;장유민;박성재;장원경
    • 한국가축번식학회지
    • /
    • 제25권2호
    • /
    • pp.119-124
    • /
    • 2001
  • 본 연구는 한우 난포발달에 있어서 난포액 및 inhibin의 생리적 역할을 검토하기 위해 수행되었다. Anti-inhibin serum(AI)생산을 위해 사용된 항원은 porcine inhibin-$\alpha$-subunit 19~32의 peptide를 사용하여 adjuvant 용액을 혼합, 앙고라종 토끼 5두(체중 2.5kg)에게 주 2회 간격으로 면역 실시 후 52일째의 토끼로부터 항혈청을 생산하였다. 과립막 세포의 체외배양을 위해 D-MEM(10% FCS와 antibiotics를 첨가)을 배양액으로 하여 1$\times$$10^{6}$ cells/$m\ell$로 조절하였으며, 호르몬은 RIA 및 ELISA법으로 분석하였다. Western blotting법에 의해 과립막 세포 및 황체조직의 각 세포질을 SDS-PAGE로 분리하여 nitro cellulose membrane에 transfer하여 검토한 결과, 직경 1.0 cm의 성숙 난포의 granulosa cell의 세포질에서 특이하게 Inhibin이 존재하고 있음이 확인되었으나, 황체조직 및 성숙 난포에서는 검출되지 않았다. 난포 크기별 난포액의 progesterone 및 estradiol-17$\beta$을 농도를 분석한 결과, estradiol-17$\beta$농도는 난포 크기가 직경 2.0 cm부터 유의적으로 높았으나 난포 크기가 적을수록 감소되었다. 이에 반해, Progesterone 농도는 직경 2.0 cm 난포에서 가장 높았으며 난포 크기가 적을수록 낮았다. 과립막 세포의 48시간 체외배양에서 bFF 5% 처리구와 bFF 5%+AI 5% 처리구에서는 progesterone은 대조구보다 유의적으로 억제되었으나, AI 5% 단독 처리구에서는 대조구와 큰 차이가 없었다. 또한, estradiol-17$\beta$농도는 5% AI구와 5% AI+5% bFF 처리구에서는 대조구에 비해 증가하였다. 그러나, 5% bFF 단독처리구에서는 대조구와 큰 차이가 없었다. 이상의 결과로, 한우에 있어서 성숙난포에 존재하는 Inhibin은 AI처리에 의해 내인성 Inhibin의 기능이 약하되어 FSH분비를 조절하는 역할을 함으로써 난포발달 및 난포세포의 스테로이드호르몬합성에 중요하게 관여하고 있는 것으로 사료된다.

  • PDF

난포액이 생쥐 및 인간수정란의 체외발생에 미치는 영향 (Effects of Follicular Fluid on Development of Mouse and Human Embryos In Vitro)

  • 윤혜균;윤산현;임진호;이훈택;정길생
    • 한국가축번식학회지
    • /
    • 제18권1호
    • /
    • pp.71-81
    • /
    • 1994
  • These experiments were carried out to investigate the effects of human follicular fluid (hFF) as a protein supplement on development of mammalian embryo as well as to find out ways toward effective use of hFF. The developmental rates of mouse embryos to the blastocyst and implantation stages were significantly higher in T6 +hFF than T6+hFCS. Classified hFF according to the maturity of contained oocytes (M-hFF and Im-hFF), and compared the rates of development of mouse embryo cultured in M-hFF or Im-hFF to culture medium T6. Total protein, albumin and estradiol concentrations were higher in M-hFF than Im-hFF (P<0.05). The developmental rates of mouse embryos to the blastocyst and hatching blastocyst stages cultured in Im-hFF were significantly lower than those in M-hFF and the basic medium. In accordance of the results of human IVF, hFF has been divided into 4 groups. The developmental rates of mouse embryos to the blastocyst stage in presense of hFF from pregnant patients, who have good grade embryos, were significantly higher than those in hFF from patients who have poor grade embryos or were not pregnant. In addition, the rates of development of human embryo were compared in presense of BSA, hFF or hFCS. The developmental rates of human embryos cultured in Ham's F10+hFF were significantly higher than those in the Ham's F10+BSA. These results suggests that the culture system using hFF could improve the development ability of mammalian embryos and the viability of blastocysts cultured in vitro.

  • PDF

Lower growth factor expression in follicular fluid undergone in-vitro fertilization

  • Han, Myoung-Seok;Park, Seung-Bin;Park, Bang-Ja
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제38권4호
    • /
    • pp.210-215
    • /
    • 2011
  • Objective: This study was performed to identify whether growth and differentiation factor-9 (GDF-9) and transforming growth factor-${\beta}1$ (TGF-${\beta}1$) expressions would be lower in the follicular fluid (FF) of those over age 35 who underwent IVF than under age 35. Methods: A total of 24 IVF cycles (20 patients) were included in this study. All of patients were stimulated for IVF by the GnRH short protocol and divided into two groups for analysis, according to their age: <35 group (14 cycles, 11 patients) vs. ${\geq}35$ group (10 cycles, 9 patients). The expression levels of GDF-9 and TGF-${\beta}1$ were determined by western blotting and quantitative enzyme-linked immunosorbent assay. Results: The numbers of retrieved oocytes and metaphase II oocytes were significantly lower in the ${\geq}35$ group. Lower expression of GDF-9 and TGF-${\beta}1$ by western blotting in the ${\geq}35$ group were observed as well. The mean GDF-9 and TGF-${\beta}1$ levels by enzyme-linked immunosorbent assay were lower in the ${\geq}35$ group. The values were $6,850.5{\pm}928.4$ ng/L vs. $3,333.3{\pm}1,089.2$ ng/L of GDF-9 ($p$ <0.05) and $3,844.1{\pm}571.1$ ng/L vs. $2,187.7{\pm}754.0$ ng/L of TGF-${\beta}1$ ($p$ <0.05). A negative correlation between GDF-9 and age was observed (r=-0.546, $p$=0.006). Conclusion: GDF-9 and TGF-${\beta}1$ production from stimulated ovaries during IVF appears to decrease with age.

Pioglitazone treatment decreases follicular fluid levels of tumor necrosis factor-${\alpha}$ and interleukin-6 in patients with polycystic ovary syndrome

  • Kim, Chung-Hoon;Ahn, Jun-Woo;You, Rae-Mi;Kim, Sung-Hoon;Chae, Hee-Dong;Kang, Byung-Moon
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제38권2호
    • /
    • pp.98-102
    • /
    • 2011
  • Objective: To investigate the effects of pioglitazone on controlled ovarian stimulation (COS), IVF outcomes, and follicular fluid (FF) cytokine concentrations in patients with polycystic ovary syndrome (PCOS). Methods: Eighty-six infertile patients with PCOS resistant to clomiphene citrate were randomized to receive pioglitazone (30 mg/day) or placebo on the starting day of oral contraceptive (OC) pretreatment, followed by an IVF protocol using a GnRH antagonist. Pioglitazone or placebo was administered once daily from the starting day of OC to the day of hCG injection. Results: Total dose and days of recombinant follicle-stimulating hormone administered, and the numbers of retrieved and mature oocytes, were significantly lower in the pioglitazone group than in the control group. FF tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) and interleukin-6 (IL-6) concentrations at oocyte retrieval were also significantly lower in the pioglitazone group. The clinical pregnancy rate was higher and the incidence of severe ovarian hyperstimulation syndrome was lower in the pioglitazone group, but the differences were not statistically significant. Conclusion: Pioglitazone reduces FF TNF-${\alpha}$ and IL-6 levels, and may improve ovarian response to COS in patients with PCOS.

사람의 과배란 유도 후 난소 반응별 난포액 내 단백질 변화 (The Change of Protein Patterns in Follicular Fluid on Ovarian Response Following Controlled Ovarian Hyperstimulation (COH) of Human)

  • 이채식;이상찬;노용호;오대식;이용승;송은지;정희태;양부근;박춘근
    • Reproductive and Developmental Biology
    • /
    • 제35권3호
    • /
    • pp.273-280
    • /
    • 2011
  • It was conducted the experiment, divided into three groups as normal, poor and polycystic ovary syndrome, to detect the change of protein patterns in follicular fluid on ovarian response following controlled ovarian hyperstimulation for human IVF outcome. In the normal group, it was confirmed reproducible 57 spots in the detected total 81 spots. Then 1 spot was not found in the other groups. In the poor responder group, it was found reproducible 53 spots in the detected total 98 spots. 6 spots were down-regulation and 7 spots were up-regulation comparable with normal group. There were not 5 spots in poor responder group comparable with other groups. In the polycystic ovary syndrome group, it was expressed reproducible 53 spots in the detected total 80 spots and 3 spots were just expressed in this group. However, 4 spots were not found in polycystic ovary syndrome. 9 spots were up-regulation comparable with normal group. Significant up and down-regulation spots among the each groups were identified. The results were a cytosolic carboxypeptidase, a signal-induced proliferation-associated protein 1, a ceruloplasmin, a keratin(type II cytoskeletal 1), a polypeptide N-acetylgalactosantinyltransferase 2, a serine/threonine-protein phosphatase 4 regulatory subunit 4. It was identified that 8 spots, 6 kinds of protein are corresponded with NCBInr database research, but 10 spots were failed in the identification. In conclusion, it has been confirmed change and expression of protein on the ovarian response following COH of human.

무력정자증 환자에서 인간 난포액과 SpermGrad를 이용한 정자처리법의 비교 (Comparison between Human Follicular Fluid and SpermGrad for Sperm Preparation in Asthenozoospermia)

  • 정연경;이정렬;문정희;김현준;한상훈;지병철;구승엽;서창석;김석현;최영민;김정구;문신용
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제33권1호
    • /
    • pp.53-60
    • /
    • 2006
  • 목 적: 보조생식술에서의 정자처리법으로서 인간 난포액을 이용한 swim-down 방법의 유용성을 확인해 보고자 하였다. 연구방법: 분당서울대학교병원 산부인과에서 불임평가 목적으로 정액검사를 시행할 때 정자무력증 (asthenozoospermia, sperm motility < 50%)을 보이는 12명의 남성을 대상으로 하였다. 이들에서 검사 후 남은 정액을 100% 인간 난포액을 이용한 swim-down법과 SpermGrad를 이용한 밀도차 분리법을 적용하여 각각 처리하고 컴퓨터 정액분석기를 이용하여 정액검사를 시행하였다. 결 과: 두 군 모두에서 운동성과 빠른 운동성 정자의 비율, VCL (curvilinear velocity), ALH (amplitude of lateral head displacement)치 및 과활동성 정자의 비율이 통계적으로 유의하게 상승하였고 LIN (mean linearity)치는 유의하게 감소하였다. 100% 인간 난포액을 이용한 swim-down법에서 정자의 운동성이 SpermGrad를 이용한 밀도차분리법에 비하여 유의하게 높게 나타났으며 ($81.2{\pm}4.7$ vs. $67.6{\pm}2.3$, p=0.02), 다른 변수들은 두 군에서 차이를 보이지 않았다. 결 론: 100% 인간 난포액을 이용한 swim-down법은 정자무력증을 보이는 경우 유용한 정자 처리법으로 사료된다.

사람 난포액에 존재하는 72 kDa Geletinase로부터 GA110을 만드는 PDI-like PDI-like Enzyme (PDI-like Enzyme in Human Follicular Fluid Converts 72 kDa Gelatinase into GA110)

  • 김지수;김해권
    • 한국발생생물학회지:발생과생식
    • /
    • 제7권2호
    • /
    • pp.105-112
    • /
    • 2003
  • 최근 사람의 난포액에 존재하는 gelatinase 중 EDTA처리에 의해 활성이 크게 증가하는 GA110을 발견하였으며, 본 연구에서는 이러한 GA110이 만들어지는 기작을 알아보고자 하였다. 먼저, protein disulfide isomerase(PDI)가 관여하는지 알아보기 위해 PDI 저해제를 처리하여 GA110의 활성을 조사하였다. 난포액에 EDTA를 처리하기 전에 저해제를 첨가하여 반응시키면 저해제 의 농도가 증가할수록 GA110의 활성 이 감소하였으나 반면 72 kDa gelatinase의 활성은 증가하였다. 그러나 EDTA를 처 리 한 후 저해제를 첨가하여 반응시키면 GA110의 활성에 영 향을 주지 못하였다. 다음으로 72 kDa gelatinase로부터 GA110이 만들어지는 과정에 관여하는 효소를 분리하기 위하여 chromatography 방법을 이용하였으며 이렇게 분리한 효소와 기질을 반응시켜 GA110이 만들어지는 것을 확인하였다. 또한 PDI 항체를 이용하여 immunoblotting을 수행한 결과 난포액 내에 PDI보다 분자량은 약간 작지만 항체와 반응하는 단백질이 존재하는 것으로 나타났다. 이러한 결과로 보아 EDTA 처리로 인해 난포액에서 나타나는 GA110은 난포액 내에 존재하는 PDI와 유사한 효소의 활성화로 인해 72 kDa gelatinase 서로간에 이황화 결합이 형성되어 결국 72 kDa gelatinase dimer인 GA110이 만들어지는 것으로 추측된다.

  • PDF

체외수정시술을 위한 성선자극호르몬 과배란유도에 Limited Ovarian Reserve를 갖는 환자에서 성장호르몬의 사용 (Cotreatment with Growth Hormone in Controlled Ovarian Hyperstimulation for IVF in Women with Limited Ovarian Reserve)

  • 김선행;장기훈;구병삼
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제21권3호
    • /
    • pp.241-245
    • /
    • 1994
  • Despite increasing success rate of IVF, poor response to ovarian stimulation remains a problem. So, attempts to improve ovarian responses, for example, by using combined gonadotropin-releasing hormone analogue(GnRH-a) and human menopausal gonadotropin(hMG) have shown limited success. It is reported that response of granulosa cells in vitro to FSH is stimulated by co-incubation with IGF-l, and IGF-l production can be increased by growth hormone. This suggest that combination regimen of G.H. and hMG may augment follicle recruitment. In fifteen patients who had previous history of poor ovarian response to gonadotropin stimulation after pituitary suppression with mid -luteal GnRH-a, the effectiveness of cotreatment with G.H. in IVF program was evaluated using a combination regimen of G.R. and hMG at Korea University Hospital IVF Clinic. Ovarian responses to gonadotropin stimulation in control and GH-treated cycles assessed by total dose and duration of hMG treatment, follicular development and peak $E_2$ level, number of eggs retrieved, and fertilization rates were also assessed. In each group, serum and follicular fluid IGF-1 concentrations on day of egg collection were measured by RIA after acidification and extraction by reveresed phase chromatography. Patients receiving G.H. required fewer days and ampules of gonadotropins, developed more oocytes, and more embryos transferred. But, the differences were not statistically significant, except the duration of hMG treatment. Our data showed a significantly higher concentration of IGF-l in the serum, not in the follicular fluid, of patients treated with G.H. compared with control group. These data suggest that growth hormone treatment does not improve the ovarian response in women with limited ovarian reserve to gonadotropin stimulation for IVF.

  • PDF

The association of follicular fluid volume with human oolemma stretchability during intracytoplasmic sperm injection

  • Inoue, Taketo;Yamashita, Yoshiki;Tsujimoto, Yoshiko;Yamamoto, Shuji;Taguchi, Sayumi;Hirao, Kayoko;Uemura, Mikiko;Ikawa, Kayoe;Miyazaki, Kazunori
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제44권3호
    • /
    • pp.126-131
    • /
    • 2017
  • Objective: Oocyte degeneration often occurs after intracytoplasmic sperm injection (ICSI), and the risk factor is low-quality oocytes. The follicular fluid (FF) provides a crucial microenvironment for oocyte development. We investigated the relationships between the FF volume aspirated from individual follicles and oocyte retrieval, oocyte maturity, oolemma stretchability, fertilization, and development. Methods: This retrospective study included data obtained from 229 ICSI cycles. Ovarian stimulation was performed according to a gonadotropin-releasing hormone antagonist protocol. Each follicle was individually aspirated and divided into six groups according to FF volume ( < 1.0, 1.0 to < 2.0, 2.0 to < 3.0, 3.0 to < 4.0, 4.0 to < 5.0, and ${\geq}5.0mL$). Oolemma stretchability during ICSI was evaluated using a mechanical stimulus for oolemma penetration, that is, the stretchability was assessed by oolemma penetration with aspiration (high stretchability) or without aspiration (low stretchability). Results: Oocyte retrieval rates were significantly lower in the < 1.0 mL group than in the ${\geq}1.0mL$ groups (46.0% [86/187] vs. 67.5%-74.3% [172/255 to 124/167], respectively; p< 0.01). Low oolemma stretchability was significantly more common in the < 1.0 mL group than in the ${\geq}1.0mL$ groups during ICSI (22.0% [13/59] vs. 5.8%-9.4% [6/104 to 13/139], respectively; p= 0.018). There was a relationship between FF volume and oolemma stretchability. However, there were no significant differences in the rates of fertilization, cleavage, ${\geq}7$ cells at day 3, and blastocyst development among all groups. Conclusion: FF volume is potentially associated with the stretchability of metaphase II oolemma during ICSI. Regarding oolemma stretchability, ensuring a uniform follicular size during ovarian stimulation is crucial to obtain good-quality oocytes.